文献速递神经重症脑血管病外科

特发性颅内压增高研究进展

An update on idiopathic intracranial hypertension.
PubMed 文献 · Acta Neurochir (Wien) · 2016-12-24

本文为叙述性综述,总结特发性颅内压增高(IIH)的病因学与治疗最新信息,并尝试统一Dandy、Friedman和Wall自1937年至今的诊断标准。现有文献以队列研究、病例对照研究、系统综述和其他叙述性综述为主,尚缺乏I类指南及系统综述与随机对照试验。

要点

  • IIH发病率呈稳步上升趋势。
  • 文献提出多种基于脑脊液流动的病理生理学理论。
  • 目前尚无I类指南可指导IIH的临床决策。

核心结论

  • 迄今为止尚无I类指南可作为IIH管理的决策依据。
  • 已注意到缺乏系统综述和随机对照试验,若研究聚焦于此可制定标准化治疗方案。

研究设计与样本

  • 本文为叙述性综述,旨在更新IIH的当前观点、评估已有研究投入并思考未来研究方向。
  • 所纳入的绝大多数文献为队列研究、病例对照研究、系统综述和其他叙述性综述。

主要发现

  • IIH的发病率呈稳步上升趋势。
  • 文献中提出了多种基于脑脊液流动的病理生理学理论。
  • 作者尝试融合文献中发表的三种检测IIH的诊断方法,同时保留每种方法各自的特点。
  • 基于循证试验,评估了当前乙酰唑胺与安慰剂或与托吡酯比较的应用情况。
  • 在干预领域,对于警示性症状及每种情况下最合适的手术方式似乎存在共识;对于横窦支架置入的适应证及其风险/获益比存在一些分歧。

关键数值与推荐

  • 作者尝试统一Dandy、Friedman和Wall自1937年至今建立的诊断标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 文献提供的循证信息很少,不足以指导治疗决策。
  • 迄今为止尚无I类指南可作为IIH管理的决策依据。
  • 已注意到缺乏系统综述和随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Idiopathic intracranial hypertension (IIH) is still a grey area in the knowledge of the aetiology, diagnosis and management of neurosurgical diseases. The definition of IIH has been reviewed over time and many hypotheses have been expressed as cause of the disease. The literature supplies very little evidence-based information to guide our decision-making process when it comes to treat the disease. In this review we sum up the latest information regarding the aetiology and therapy of IIH. Additionally, we make an attempt to unify the diagnostic criteria of Dandy, Friedman and Wall established from 1937 to date. METHOD: In this narrative review, we attempt to update the current standpoint to IIH, evaluate the input until now and consider future directions for research. The vast majority of the literature consisted of cohort studies, case control studies, systematic reviews and other narrative reviews. RESULTS: Pathophysiology: The incidence of IIH is steadily increasing. Several pathophysiological theories have been proposed in the literature based on the flow of cerebrospinal fluid. DIAGNOSIS: We attempt to fuse all the three diagnostic approaches published in the literature that detect IIH, while preserving the individual characteristics of each approach. TREATMENT: Based on evidence-based trials, the current use of acetazolamide in comparison with placebo or with topiramate has been evaluated. In the interventions' field, there seems to be a consonance about the alarming symptoms and what the most suitable operation is in each case. There is some disagreement about the indications for venous sinus transversus stenting and its risk/benefit ratio. CONCLUSIONS: Until now there is no class I guideline to which our decision-making can be based on for the management of IIH. A lack of systematic reviews and randomised control trials has been noted. If we focused our research on that, we could develop a standardised treatment protocol.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Portelli M, Papageorgiou PN. An update on idiopathic intracranial hypertension. Acta Neurochir (Wien). 2016. PMID: 28013373. doi:10.1007/s00701-016-3050-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。